159 related articles for article (PubMed ID: 9935171)
1. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.
Strickler HD; Kirk GD; Figueroa JP; Ward E; Braithwaite AR; Escoffery C; Drummond J; Goebel B; Waters D; McClimens R; Manns A
Int J Cancer; 1999 Jan; 80(3):339-44. PubMed ID: 9935171
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
[TBL] [Abstract][Full Text] [Related]
4. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
Marais D; Rose RC; Williamson AL
J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
[TBL] [Abstract][Full Text] [Related]
5. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
[TBL] [Abstract][Full Text] [Related]
6. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
[TBL] [Abstract][Full Text] [Related]
7. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Viscidi RP; Kotloff KL; Clayman B; Russ K; Shapiro S; Shah KV
Clin Diagn Lab Immunol; 1997 Mar; 4(2):122-6. PubMed ID: 9067643
[TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.
Touzé A; de Sanjosé S; Coursaget P; Almirall MR; Palacio V; Meijer CJ; Kornegay J; Bosch FX
J Clin Microbiol; 2001 Dec; 39(12):4344-8. PubMed ID: 11724843
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence.
Svare EI; Kjaer SK; Worm AM; Osterlind A; Moi H; Christensen RB; Meijer CJ; Walboomers JM; van den Brule AJ
Int J Cancer; 1998 Jan; 75(1):1-8. PubMed ID: 9426682
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
13. Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.
Olsen AO; Dillner J; Gjøen K; Magnus P
Genitourin Med; 1997 Apr; 73(2):131-5. PubMed ID: 9215097
[TBL] [Abstract][Full Text] [Related]
14. Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
Ryser MD; Rositch A; Gravitt PE
J Infect Dis; 2017 Sep; 216(5):604-611. PubMed ID: 28931221
[TBL] [Abstract][Full Text] [Related]
15. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women.
Svare EI; Kjaer SK; Nonnenmacher B; Worm AM; Moi H; Christensen RB; van den Brule AJ; Walboomers JM; Meijer CJ; Hubbert NL; Lowy DR; Schiller JT
J Infect Dis; 1997 Oct; 176(4):876-83. PubMed ID: 9333144
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
Tay SK; Oon LL
Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
[TBL] [Abstract][Full Text] [Related]
19. Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union.
Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grujnberga V; Grujnberg A; Juschenko A; Johansson B; Tosi P; Cintorino M; Santopietro R; Syrjänen K
Sex Transm Dis; 2003 Sep; 30(9):680-4. PubMed ID: 12972789
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
Hisada M; van den Berg BJ; Strickler HD; Christianson RE; Wright WE; Waters DJ; Rabkin CS
Cancer Causes Control; 2001 May; 12(4):335-41. PubMed ID: 11456229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
